Researchers at Rutgers Robert Wood Johnson Medical School are reporting the first instance of COVID-19 triggering a rare recurrence of potentially serious blood clots in people's arms.
A new analysis of the effects of SARS-CoV-2, the virus causing the current pandemic, on the human body has provided novel insights into the nature of resilience and how we deal with stressful situations. Using COVID-19 as an example, the findings provide a new framework that may be central to managing this disease, minimise the likelihood of ferocious viral outbreaks in the future and deal with other major stresses.
Better designed vaccines for insect-spread viruses like dengue and Zika are likely after researchers discovered models of immature flavivirus particles were originally misinterpreted. Researchers from The University of Queensland and Monash University have now determined the first complete 3D molecular structure of the immature flavivirus, revealing an unexpected organization.
Scientists at UCL have identified a new immunotherapy to combat the hepatitis B virus (HBV), the most common cause of liver cancer in the world.
What The Study Did: This is a qualitative study that evaluates a crowdsourcing open call to gather community input for engaging the university community in COVID-19 safety strategies.
What The Study Did: Associations of staffing and testing interventions with COVID-19 transmission in nursing homes are examined in this decision analytical modeling study.
What The Study Did: Researchers analyzed changes in filled prescriptions for naloxone (medication to reverse opioid overdoses) during the COVID-19 pandemic in the United States and compared them with changes in opioid prescriptions and overall prescriptions.
According to data from a cohort of adult and pediatric patients with antibody deficiencies, patients that often fail to make protective immune responses to infections and vaccinations showed robust T-cell activity and humoral immunity against SARS-CoV-2 structural proteins. The new study, led by researchers at Children's National Hospital, is the first to demonstrate a robust T-cell response against SARS-CoV-2 in immunocompromised patients.
In a new study from Beth Israel Deaconess Medical Center, researchers evaluated the immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women who received either the Pfizer or Moderna COVID-19 vaccines, finding that both triggered immune responses.
New research led by the University of Kent has found that people fail to recognise the role of factory farming in causing infectious diseases.